We position ourselves as your lifelong partner in health
The half-life of semaglutide is approximately seven days, meaning half the drug is still in your system a full week later
Among these patients, semaglutide reduced major adverse cardiovascular events by 28% (hazard ratio 0.72, 95% CI 0.60-0.87)an even greater benefit than seen in the overall trial population
People considering GLP-1 treatments often worry about rare side effects, such as increased risk of thyroid cancer, but gallstones happen in a decent subset of these patients, says Armen Yerevanian, an endocrinologist at Massachusetts General Hospital
Under standard regulatory review timelines, which typically take 6 to 10 months, official commercial approval and retail availability are projected for late 2027 or early 2028
Slows gastric emptying, making you feel fuller longer